Utility of the PASE questionnaire, psoriatic arthritis (PsA) prevalence and PsA improvement with anti-TNF therapy: results from the PRISTINE trial.
about
Utility of the PASE questionnaire, psoriatic arthritis (PsA) prevalence and PsA improvement with anti-TNF therapy: results from the PRISTINE trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Utility of the PASE questionna ...... sults from the PRISTINE trial.
@en
Utility of the PASE questionna ...... sults from the PRISTINE trial.
@nl
type
label
Utility of the PASE questionna ...... sults from the PRISTINE trial.
@en
Utility of the PASE questionna ...... sults from the PRISTINE trial.
@nl
prefLabel
Utility of the PASE questionna ...... sults from the PRISTINE trial.
@en
Utility of the PASE questionna ...... sults from the PRISTINE trial.
@nl
P2093
P2860
P1476
Utility of the PASE questionna ...... sults from the PRISTINE trial.
@en
P2093
Abrar A Qureshi
Andrew S Koenig
Deborah Robertson
M Elaine Husni
Ronald Pedersen
P2860
P356
10.3109/09546634.2013.800185
P577
2013-06-20T00:00:00Z